HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of the structure of branched polypeptide carrier on intracellular delivery of daunomycin.

Abstract
The conjugate of acid labile cis-aconityl-daunomycin (cAD) with branched chain polypeptide, poly[Lys(Glui-DL-Alam)] (EAK) was very effective against L1210 leukemia in mice. However, Dau attached to a polycationic polypeptide, poly[Lys(Seri-DL-Alam)] (SAK) exhibited no in vivo antitumor effect. In order to understand this difference we have performed comparative in vitro studies to dissect properties related to interaction with the whole body (e.g., biodistribution) from those present at cellular or even molecular level. We report here (a) the kinetics of acid-induced Dau liberation, (b) interaction with DPPC phospholipid bilayer, (c) in vitro cytotoxic effect on different tumor cells, and (d) intracellular distribution in HL-60 cells of polycationic (cAD-SAK) and amphoteic (cAD-EAK) conjugates. Fluorescence properties of the two conjugates are also reported. Our findings demonstrate that the kinetics of the drug release, intracellular distribution and in vitro cytotoxic effect are rather similar, while the effect on DPPC phospholipid bilayer and fluorescence properties of the two conjugates are not the same. We also found that the in vitro cytotoxicity is cell line dependent. These observations suggest that the structure of the polypeptide carrier could have marked influence on drug uptake related events.
AuthorsJudit Reményi, Gabriella Csík, Péter Kovács, Francesca Reig, Ferenc Hudecz
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1758 Issue 3 Pg. 280-9 (Mar 2006) ISSN: 0006-3002 [Print] Netherlands
PMID16500616 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Drug Carriers
  • Intercellular Signaling Peptides and Proteins
  • Liposomes
  • Peptides
  • Proteins
  • poly(lysyl(seryl(i)-alanyl(m)))
  • poly(lysyl-(glutamyl(i)-alanine(m)))
  • 1,2-Dipalmitoylphosphatidylcholine
  • N-aconityldaunomycin
  • Daunorubicin
Topics
  • 1,2-Dipalmitoylphosphatidylcholine (chemistry)
  • Animals
  • Daunorubicin (analogs & derivatives, chemistry, metabolism)
  • Drug Carriers (chemistry)
  • HL-60 Cells
  • Humans
  • Intercellular Signaling Peptides and Proteins
  • Leukemia L1210 (drug therapy)
  • Leukemia, Promyelocytic, Acute (drug therapy)
  • Liposomes (chemistry)
  • Mice
  • Molecular Structure
  • Peptides (chemistry)
  • Proteins (chemistry)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: